PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis
Adult
Male
0301 basic medicine
Gene Expression Profiling
NF-kappa B
Kaplan-Meier Estimate
Middle Aged
Hypoxia-Inducible Factor 1, alpha Subunit
Neoplasm Proteins
3. Good health
Gene Expression Regulation, Neoplastic
MicroRNAs
03 medical and health sciences
Cell Movement
Cell Line, Tumor
Cluster Analysis
Humans
Female
Neoplasm Invasiveness
Neoplasm Grading
Hypoxia
Aged
Neoplasm Staging
DOI:
10.1007/s00109-015-1350-7
Publication Date:
2015-11-09T00:31:55Z
AUTHORS (5)
ABSTRACT
Phosphatase of regenerating liver-3 (PRL-3) has been implicated in controlling cancer cell invasiveness. Deregulated expression of PRL-3 is involved in cancer progression and predicts poor overall survival. Recent studies have revealed critical roles for microRNAs in various cellular processes, including tumorigenic development. In this study, we aimed to explore the linkage between PRL-3 and microRNAs in gastric cancer. We found that PRL-3 transcript levels were positively correlated with miR-210 levels in gastric cancer tissues. In gastric cancer cells, PRL-3 upregulated miR-210 expression in a HIF-1α-dependent fashion under normoxia and hypoxia. In addition, PRL-3 activated NF-κB signaling and promoted HIF-1α expression through modulating phosphorylation of p65. NF-κB signaling, HIF-1α, and miR-210 partially contributed to PRL-3-induced migration and invasion. Furthermore, the levels of PRL-3, HIF-1α, and miR-210 transcripts inversely affected the overall survival of gastric cancer patients. Our work identified the existence of a PRL-3-NF-κB-HIF-1α-miR-210 axis, thus providing new insight into the role of PRL-3 in promoting gastric cancer invasiveness.PRL-3 regulates microRNA in gastric cancer. PRL-3 elevates hsa-miR-210 by upregulating HIF-1α. PRL-3 activates a NF-κB-HIF-1α-miR-210 axis by enhancing the phosphorylation of p65. PRL-3 promotes cell migration and invasion via the NF-κB-HIF-1α-miR-210 axis. High levels of PRL-3 and miR-210 are related with poor OS in gastric cancer.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (29)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....